EPISODE · Dec 28, 2020 · 8 MIN
E2: Evaluating Safety and Efficacy of Treatment for Wet AMD
from Retinal Physician Insider · host Retinal Physician Insider
Peter Kaiser, MD, and Timothy Murray, MD, MBA, discuss the HAWK and HARRIER phase 3 studies evaluating the safety and efficacy of brolucizumab for wet AMD.
What this episode covers
Peter Kaiser, MD, and Timothy Murray, MD, MBA, discuss the HAWK and HARRIER phase 3 studies evaluating the safety and efficacy of brolucizumab for wet AMD.
NOW PLAYING
E2: Evaluating Safety and Efficacy of Treatment for Wet AMD
0:00
8:27
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Retinal Physician Insider?
This episode is 8 minutes long.
When was this Retinal Physician Insider episode published?
This episode was published on December 28, 2020.
What is this episode about?
Peter Kaiser, MD, and Timothy Murray, MD, MBA, discuss the HAWK and HARRIER phase 3 studies evaluating the safety and efficacy of brolucizumab for wet AMD.
Can I download this Retinal Physician Insider episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!